Home > Riviste > Minerva Anestesiologica > Fascicoli precedenti > Minerva Anestesiologica 2022 October;88(10) > Minerva Anestesiologica 2022 October;88(10):771-9

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

ORIGINAL ARTICLE   

Minerva Anestesiologica 2022 October;88(10):771-9

DOI: 10.23736/S0375-9393.22.16297-8

Copyright © 2022 EDIZIONI MINERVA MEDICA

lingua: Inglese

Increased preoperative serum vitamin B12 level as a predictor of postoperative mortality in patients undergoing cardiac surgery

Seohee LEE 1, Karam NAM 1 , Sun-Young JUNG 2, Dongnyeok PARK 1, Jae-Woo JU 1, Jinyoung BAE 1, Youn-Joung CHO 1, Yunseok JEON 1

1 Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea; 2 College of Pharmacy, Chung-Ang University, Seoul, South Korea



BACKGROUND: Serum vitamin B12 level is a useful prognostic marker for various conditions. The present study examined whether preoperative serum vitamin B12 level can predict mortality after cardiac surgery.
METHODS: The present observational study comprised adult patients who underwent cardiac surgery at our institute between 2012 and 2019. The performance of preoperative vitamin B12 level in discriminating postoperative in-hospital mortality, the primary outcome of this study, was assessed by receiver operating characteristic (ROC) curve analysis. After dichotomizing vitamin B12 level using Youden’s J Index, weighted logistic regression analysis was performed. Cumulative all-cause mortality, the secondary outcome, was also compared using the Kaplan-Meier estimator and Cox regression analysis.
RESULTS: A total of 973 patients were analyzed. The area under the ROC curve of vitamin B12 level for predicting in-hospital mortality was 0.76 (95% confidence interval [CI]: 0.73-0.78). Weighted logistic regression analysis revealed that the high vitamin B12 group (>726 pg/mL) had a significantly increased risk of in-hospital mortality compared to the low vitamin B12 group (adjusted odds ratio, 12.01; 95% CI: 7.73-18.67). The risk of mortality was higher in the high vitamin B12 group than the low vitamin B12 group (log-rank test, P<0.001; adjusted hazard ratio, 2.41; 95% CI: 1.70-2.39). In addition, the high vitamin B12 group had significantly poorer survival than the low vitamin B12 group, even within the same EuroSCORE II stratum (< or ≥4%; log-rank test, P<0.001 and P=0.001, respectively).
CONCLUSIONS: Preoperative measurement of serum vitamin B12 level may be an alternative for predicting the prognosis of patients undergoing cardiac surgery.


KEY WORDS: Cardiac surgical procedures; Vitamin B 12; Mortality

inizio pagina